首页> 外文期刊>Balkan Medical Journal >In Vitro Effects of Ivermectin and Sulphadiazine on Toxoplasma gondii
【24h】

In Vitro Effects of Ivermectin and Sulphadiazine on Toxoplasma gondii

机译:伊维菌素和磺胺嘧啶对弓形虫的体外作用

获取原文
       

摘要

Objective: Ivermectin and sulphadiazine were tested individually to determine their in vitro effects on Toxoplasma gondii grown in human epidermoid larynx carcinoma (Hep-2) cell culture. Study Design: In-vitro study. Material and Methods: Toxoplasma growth was quantities by an enzyme immunoassay performed directly on the fixed cultures, using a rabbit anti-T. gondii immunoglobulin G as the first antibody and a phosphatase-labeled anti-rabbit immunoglobulin G as the second antibody. For each drug, regression models were used to quantify the relationship between optical density values and antimicrobial agent concentrations in the cultures. Results: The 50% inhibitory concentrations (IC50) of ivermectin and sulphadiazine were found to be 0.2 μg/mL and 7.3 μg/mL after 48 h of exposure, respectively. None of the concentrations tested for each drugs demonstrated toxicity to Hep-2 cells after 72 h of incubation. Conclusion: These results indicate that ivermectin significantly inhibited replication of the tachyzoites of T. gondii RH strain. Turkish Ba?l?k: ?vermektin ve sulfadiazinin toxoplasma gond??'ye etkinliklerinin in vitro de?erlendirilmesi Anahtar Kelimeler: Toxoplasma gondii, ivermektin, sulfadiazin, in vitro, Hep-2 Ama?: ?vermektin ile sulfadiazinin, in vitro T. gondii ile enfekte insan larenks epidermoid karsinom (Hep-2) hücrelerinde anti-toxoplasma aktiviteleri ara?t?r?lm??t?r. Gere? ve Y?ntemler: Antimikrobiyal ajanlar?n anti-Toxoplasma aktiviteleri hücre kültür tabanl? ELISA ile de?erlendirilmi?tir. Primer antikor olarak tav?an anti-T gondii immunglobulin G sekonder antikor olarak alkalen fosfataz i?aretli anti-rabbit immunglobulin G kullan?lm??t?r. Her ila? i?in, optik dansite de?erleri ile antimikrobiyal ajan konsantrasyonlar? aras?ndaki ili?ki regresyon analizi uygulanarak de?erlendirilmi?tir. Bulgular: ?vermektin ve sulfadiazinin inkübasyonun 48. saatinde, %50 inhibit?r konsantrasyon (IC50) de?erleri s?ras?yla 0.2 μg/ml ve 7.3 μg/ml olarak hesaplanm??t?r. Ayr?ca her iki ilac?n test edilen konsantrasyonlar?n?n Hep-2 hücrelerine toksik olmad??? saptanm??t?r. Sonu?: Bu sonu?lar; ivermektinin in vitro T.gondii RH su?u takizoit replikasyonunu anlaml? olarak inhibe etti?ini g?stermi?tir.
机译:目的:分别测试伊维菌素和磺胺嘧啶对人表皮样喉癌(Hep-2)细胞培养中弓形虫的体外作用。研究设计:体外研究。材料和方法:弓形虫的生长是通过使用兔抗T抗体直接在固定培养物上进行的酶免疫法进行的。刚迪免疫球蛋白G作为第一抗体,磷酸酶标记的抗兔免疫球蛋白G作为第二抗体。对于每种药物,使用回归模型来量化培养物中光密度值和抗菌剂浓度之间的关系。结果:暴露48小时后,伊维菌素和磺胺嘧啶的50%抑制浓度(IC50)分别为0.2μg/ mL和7.3μg/ mL。孵育72小时后,每种药物的测试浓度均未显示出对Hep-2细胞的毒性。结论:这些结果表明,伊维菌素显着抑制弓形虫RH菌株速殖子的复制。土耳其语:“ vermektin ve sulfadiazinin弓形虫”,在体外etetlikliklerinin de'erlendirilmesi Anahtar Kelimeler:弓形虫,伊维菌素,磺胺嘧啶,体外,Hep-2 Ama? 。gondii ile enfekte insan larenks epidermoid karsinom(Hep-2)hücrelerindeanti-toxoplasma aktiviteleri ara?t?r?lm ?? t?r。 ? ve Y?ntemler:防霉菌?抗弓形虫吗?酶联免疫吸附测定法。引物antikor olarak tav?抗T弓形虫免疫球蛋白G sekonder antikor olarak alkalen fosfataz i?aretli抗兔免疫球蛋白G kullan?lm ?? t?r。她的伊拉?我是在optisite dansite de?erleri ile antimikrobiyal ajan konsantrasyonlar吗?阿拉斯·恩达基·伊利·基·雷格森大饭店球茎:?vermektin ve磺胺嘧啶墨水48. saatinde,%50抑菌剂konsantrasyon(IC50)抑菌酶s?ras?yla 0.2μg/ ml ve 7.3μg/ ml olarak hesaplanm ?? t?r。艾尔(Ayr) saptanm ?? t?r。 Sonu?:Bu sonu?lar;依维替宁体外T.gondii RH su?u takizoit replikasyonunu anlaml? olarak inhibe etti?ini g?stermi?tir。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号